Loading...
The Impact of CYP2D6 Genotyping on Tamoxifen Treatment
Tamoxifen remains a cornerstone of treatment for patients with oestrogen-receptor-positive breast cancer. Tamoxifen efficacy depends on the biotransformation, predominantly via the cytochrome P450 2D6 (CYP2D6) isoform, to the active metabolite endoxifen. Both genetic and environmental (drug-induced)...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Molecular Diversity Preservation International
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4034025/ https://ncbi.nlm.nih.gov/pubmed/27713292 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph3041122 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|